How can Pharma Navigate Turbulent Seas? Find out in our World Preview Webinar

Anna Osborne - Evaluate

Anna Osborne

Associate Director

Published

Share:

How can Pharma Navigate Turbulent Seas? Find out in our World Preview Webinar

Anna Osborne - Evaluate

Anna Osborne

Associate Director

Published

Share:

The Evaluate World Preview report is a staple of the pharma calendar. The 2025 edition has just been published, marking the 18th year of providing forecast and trend insights to decision makers across the industry.

If you’re not familiar with the World Preview, I recommend taking a look. Not only does it provide a wealth of data including the fastest-growing therapy areas, forecasts for the top-selling drugs in 2030, and a peek at the most valuable pipeline projects, but it also provides the basis for our upcoming webinar. The webinar will include many of the data highlights from the report and will also feature discussion of the big themes in the market – and this year, I am delighted to be joining the panel.

It’s my first year stepping into the World Preview webinar and there has been so much to discuss with my fellow panelists, Norstella’s Daniel Chancellor and report author Melanie Senior. As a team, our biggest challenge has been how to keep the discussion to the 60 minute limit that our webinar department insists on!

The big themes are unlikely to be a huge surprise but they are hugely relevant to anyone in the pharma and biotech space. The rise of China as a force in biotech, ongoing uncertainties around pricing and tariffs, and the seemingly endless growth of the GLP-1 class of drugs certainly all feature. Our goal is to use the data from the report to help ground the discussion.

Here are a few of the other topics I am hoping we’ll have time to cover in the webinar:

  1. Pharma’s R&D challenges. The report data shows that R&D budget growth will remain slow, despite the 7.4% growth in market size.
  2. Therapy area trends. Where are the biggest opportunities and which areas are starting to get crowded?
  3. The dealmaking landscape. Several blockbusters are facing loss of exclusivity in the next few years. Is that starting to drive M&A or is the ongoing uncertainty holding buyers back?


I’m sure we’ll cover many other areas as well and I’m really looking forward to the conversation with Melanie and Daniel. If you’d like to ask questions of our panel, you can pre-submit them when you register which of course I encourage you to do.

I hope to see you there and feel free to check out the report ahead of the session!

World Preview Webinar: 1st July at 3pm BST/10am ET

Upcoming Webinar

World Preview 2026

Tuesday 16th June 2026 | 3pm BST

By 2032, the global pharmaceutical market is forecast to reach almost $1.9tn. Inside the innovations, dealmaking, and portfolio strategies transforming the global biopharma pipeline.

Related Content